These findings suggest that reduced SLC7A11 expression may represent a common molecular signature in both PD and DM, potentially contributing to the increased susceptibility of diabetic patients to PD‐related neurodegeneration through impaired redox homeostasis and increased ferroptosis sensitivity. This evidence concerns the gene SLC7A11 and Parkinson disease.